Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

CEJ van Rensburg (Connie Medlen)

CEJ van Rensburg (Connie Medlen)

University of Pretoria South Africa

Karen Mulkijanyan

Karen Mulkijanyan

Tbilisi State Medical University Georgia

Walber Toma

Walber Toma

Santa Cecilia University Brazil

Elisabetta Radice

Elisabetta Radice

University of Turin Italy

Alexander Kulikov

Alexander Kulikov

Siberian Division of Russian Academy of Sciences, Russia Russia

T.G Borovskaya

T.G Borovskaya

Goldberg Research Institute of Pharmacology and Regenerative Medicine Russia

Ali Sheikh Md Sayed

Ali Sheikh Md Sayed

Central South University China

Fleisher-Berkovich S

Fleisher-Berkovich S

Ben-Gurion University of the Negev Israel

Pharmacology 2018

About Conference


Conference Series invites all the participants across the globe to attend ‘10th World Congress on Pharmacology’ during Jul 30-Aug 01, 2018 in Barcelona, Spain  which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharmacology 2018 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacolo­gy one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat ac­cordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs. 

Why to attend???

Join your peers around the world focused on learning about Pharmacology and related advances, which is your single best opportunity to reach the largest assemblage of participants from the Pharmacology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Pharmacology are hallmarks of this conference. 

Target Audience: 

  • Students, Scientists, Researchers, and Faculty of Pharmaceutical Universities
  • Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
  • Business Entrepreneurs, Training Institutes, Software developing companies
  • Manufacturing Medical Devices Companies, CRO and Data Management Companies.

Sessions/Tracks

Conferences Series invites all the participants across the globe to attend '10th World Congress on Pharmacology' during Jul 30-Aug 01, 2018 at Barcelona, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharmacology 2018 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacolo­gy one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat ac­cordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.

Track 1: Pharmacology

Pharmacology  is the study of how substances interact with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals which show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are considered pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and antipathogenic capabilities.

Track 2: Neuropharmacology and Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioral form. Neuropharmacology is the study of the effects of medication on central and peripheral nervous system performance. Principles related to psychopharmacology.  Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioral problems, that are associated with, including antipsychotic, anxiolytic and anticonvulsant medications, acquired brain injury and Neurocognitive effects associated with therapeutic drugs also include mood stabilizers and treatments prescribed for disorders of attention. The treatments may cause side effects such as induction of the metabolic syndrome, type-2 diabetes related to the medications prescribed for management of psychiatric and behavioral disorders and disturbances. Ethnopsychopharmacology also deals with the biotransformation and metabolism of medications, as well as specific differential actions: i.e., CYP450 enzymatic inhibition and induction of metabolism of psychopharmacological and herbaceutical substrates.

Track 3: Clinical Pharmacology and Receptor Therapy

Clinical Pharmacology has been practiced for centuries through observing the effects of herbal remedies and early drugs on humans. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects Receptor theory for drug effects and its discovery with clinical pharmacology has stretched out to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. Drug interactions and pharmacological compatibilities include the study of pharmacokinetics that includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become especially important because of the association between drug application, microorganism abolition, and resistance.

Track 4: Pharmacokinetics and Pharmacodynamics

Pharmacodynamics is the effect that drugs have on the body; while pharmacokinetics is the study of the way in which drugs move through the body during absorption, distribution, metabolism and excretion. Pharmacokinetics influences decisions over the route of administration. For drugs to produce their effects they must interact with the body. This can happen in many ways and depends on the properties of the drug, and will be discussed later in this chapter. Pharmacokinetics influences decisions over the route of administration. The processes that occur after drug administration can be broken down into four distinct areas (known as ADME):

  • A Absorption of the drug
  • D Distribution of the drug molecules
  • M Metabolism of the parent drug
  • E Excretion or elimination of the drug and its metabolites

Track 5: Cardiovascular Pharmacology

Cardio pharmacodynamics of digitalis is most frequently used to increase the adequacy of the circulation in patients with CCF and to slow the ventricular rate in patients with atrial fibrillation or flutter NB: the main action of digitalis is its ability to increase myocardial contractility its positive isotropic action results in, a. increased cardiac output, b. decreased heart size, c. decreased venous pressure, d. decreased circulating blood volume, e. diuresis and relief of edema as digitalis frequently causes a dramatic reduction in the ventricular rate, it was originally believed this was the main effect subsequently shown to be beneficial irrespective of the HR, its predominant effects being on contractility in addition to the cardiac effects, digitalis has a direct action on, a. vascular smooth muscle b. neural tissue the later being responsible for indirect cardiac actions of the drug finally, changes to the circulation brought about by digitalis frequently result in reflex autonomic & hormonal changes which effect the CVS. Role of drugs in coronary circulation the circulatory system is busy providing oxygen and nourishment to every cell of the body, let's not forget that the heart, which works hardest of all, needs nourishment, too. Coronary circulation refers to the movement of blood through the tissues of the heart. The circulation of blood through the heart is just one part of the overall circulatory system. Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries. The endothelium is directly involved in peripheral vascular disease, stroke, heart disease, diabetes, insulin resistance, chronic kidney failure, tumor growth, metastasis, venous thrombosis, and severe viral infectious diseases. Dysfunction of the vascular endothelium is thus a hallmark of human diseases. In this review the main endothelial abnormalities found in various human diseases such as cancer, diabetes mellitus, atherosclerosis, and viral infections are addressed.

Track 6: Ethnopharmacology

Ethnopharmacology is to identify the objectives of a largely virtual field whose self-identified membership represents a diverse suite of academic and applied disciplines, as well as commercial interests. Integrative Pharmacological Investigations include conglomeration of more number of pharmacological aspects and aggregated scientific research of two or more drugs. Natural products of chemistry in drug discovery play a vital role in bringing advances in traditional drug treatments. Chemistry and structural elucidation of drugs accelerate potential treatment options in the evolving developmental changes. Natural and synthetic derivatives in pharmacological studies are important aspect of advances in the development and investigation that avoid adverse drug reactions of the synthetic medicine. Mere change in the structures of the drugs can cause potential differences in efficacy and therapeutics of drug treatment.

Track 7: Immunopharmacology

Immunopharmacology is that area of pharmacological sciences dealing with the selective variation of specific immune responses and, in particular, of immune cell subsets. The first generation of immune-modulating agents included molecules drawn from oncology.  The second generation, notably cyclosporine, exploited some natural agents able to block several signal transduction pathways.

To deal with the expanding field of immunopharmacology, some limitations are required. However, in recent years, the advances about how the immune system works have identified several molecular targets suitable for more selective modulation of immune function. These targets can be broadly divided into surface molecules and soluble mediators. Surface molecules play a fundamental role in antigen recognition, immune response activation, homing and effector functions. Soluble mediators are involved in lymphocyte proliferation and differentiation, inflammatory response and cell recruitment.

Track 8: Pharmacogenetics and Pharmacogenomics

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. The somatic mutation theory of cancer holds that these agents cause cancer by causing the mutation of somatic cells. A unique feature of inter-strand cross-links repair is that both strands of DNA must be incised to completely remove the lesion. Drug dosing guidelines accomplished in sequential steps to prevent creating multiple double-strand breaks. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers.

Track 9: Toxicology

Toxicology is the study of the undesirable effects of chemicals on living organisms. It is the study of symptoms, mechanisms, treatments and detection of poisoning, especially the poisoning of people. Principles of management of a poisoned patient and relationship between dose and its effects on the exposed organism deals with important criterion regarding the toxicity of a chemical is the dose, i.e. the amount of exposure to the substance. Hypothesis and data driven research focuses on substances that are toxic under the right conditions. The term LD50 refers to the dose of a toxic substance that kills 50 percent of test population. LD50 estimations in animals are no longer required for regulatory submissions as a part of pre-clinical development package. Toxicity associated with metabolites is the conventional relationship has been challenged in the study of endocrine disruptors. There are various specialized sub disciplines within the field of toxicology that concern diverse chemical and biological aspects of this area. Toxicology has played a significant role in verifying conclusions drawn on the basis of epidemiological findings.

Track 10: Drug Screening and Drug Discovery

Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology, screening of chemical libraries and its pharmacology, methods to determine biological targeting, by systematically perturbing and interrogating biological pathways with synthetically novel chemical tools, preclinical validation of target biology is beginning to illuminate a more cost effective and efficient paradigm for the development of novel drugs modulating novel targets.

Track 11: Advances in Pharmacological Research

Liposomes and nanoparticles: Nanoscale drug delivery systems using liposomes and nanoparticles are rising technologies for the rational delivery of chemotherapeutic drugs in the treatment various ailments. Nanoparticles present possible dangers, both medically and environmentally.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

Track 12: Ocular Pharmacology

Ocular Pharmacology deals with the pharmacological effects of drugs that act on ophthalmic diseases. The pharmacodynamics and pharmacokinetics of ocular drugs is essentials for enhancing the therapeutic efficacy of the drug. Advanced studies in the drugs related to eye is important to for faster drug delivery and hence the drug action.

Track 13: Biochemical pharmacology

It is based on principles of drug action. Biochemical pharmacology uses the methods of biochemistry, biophysics, molecular biology, structural biology, cell biology, and cell physiology to define the mechanisms of drug action and how drugs influence the organism by studies on intact animals, organs, cells, sub cellular compartments and individual protein molecules.  It explores the range of biochemical targets and mechanisms. It covers research on the pharmacodynamics and pharmacokinetics of drugs and non-therapeutic xenobiotics. It also involves in elucidation of cellular and tissue functions at the biochemical and molecular levels, the modification of cellular phenotypes by genetic, transcriptional or translational or drug or compound-induced modifications.

Track 14: Pharmacoepidemiology and Pharmaco-economics

Pharmacoepidemiology is the study of the utilization and effects of drugs in large numbers of people; it provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects. It can be called a bridge science spanning both clinical pharmacology and epidemiology. Pharmacoepidemiology concentrates on clinical patient outcomes from therapeutics by using methods of clinical epidemiology and applying them to understanding the determinants of beneficial and adverse drug effects, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions, and the effects of medication non-adherence. Pharmacovigilance is a part of Pharmacoepidemiology that involves continual monitoring, in a population, for unwanted effects and other safety concerns arising in drugs that are already on the market. Pharmacoepidemiology sometimes also involves the conduct and evaluation of programmatic efforts to improve medication use on a population basis.

Track 15: Pharmacological Testing

Development of medication is a vital concern to medicine. The metabolic stability and the reactivity of a library of candidate drug compounds have to be assessed for drug metabolism and toxicological studies. Many methods of pharmacological tests have been proposed for quantitative predictions in drug metabolism. If the chemical structure of a medicinal compound is altered to some extent, this could slightly or noticeably alter the medicinal properties of the compound based on the level of alteration as it relates to the structural composition of the substrate or receptor site on which it exerts its medicinal effect, a concept referred to as the structural activity relationship (SAR). When a useful activity has been identified, chemists will make many similar compounds called analogues, in an attempt to maximize the desired medicinal effect(s) of the compound.

Track 16: Nursing Pharmacology

Pharmacology for nurses is one of the most important elements in nursing education. It is the field is science that is related to management of drugs as per the disease profile of the patient. Nursing pharmacology is dealt with vigilance over the drug action on the patients from the initial stage of drug administration and further monitoring and observing the effects.

Track 17: Entrepreneurs Investment Meet

Track 18: Market Analysis of Pharmacology

Past Conference Report

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Pharmacology 2017 a wonderful event!

Conference Series LLC hosted 9th World Congress on Pharmacology scheduled during September 04-06, 2017 at Hotel Novotel Marne la Vallée Noisy le Grand, Paris, France with the theme “Grooming the Pharmacological Boundaries for Drug Discovery and Development"

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

  • Pharmacology
  • Neuropharmacology
  • Psychopharmacology
  • Advances in Pharmacological Research
  • Ethnopharmacology
  • Toxicology
  • Drug Screening and Discovery
  • Pharmacokinetics and Pharmacodynamics
  • Biochemical Pharmacology
  • Pharmacological Testing

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

  • Kjell Fuxe, Karolinska Institutet, Sweden
  • Zhi-Yi Zhang  TESARO, Inc., USA
  • María Esperanza Avella Vargas, Military University of New Granada, Columbia
  • Layla E Borham, Cairo University, Saudi Arabia
  • Sanaa S Botros, Theodor Bilharz Research Institute, Egypt

Conference series LLC thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

With the grand success of Pharmacololgy 2017, Conference Series LLC take the immense pleasure to announce the “10th World Congress on Pharmacology" to be held during July 30-August 01, 2018 at Barcelona, Spain.

For More details visit: http://pharmacology.pharmaceuticalconferences.com

To Collaborate Scientific Professionals around the World

Conference Date Jul 30-Aug 01, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Day 1 Day 2 Day 3

Supported By

Biochemistry & Pharmacology: Open Access Journal of Clinical & Experimental Pharmacology Cardiovascular Pharmacology: Open Access

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos